Total Pageviews

Friday, 15 April 2011

Byetta and Victoza on PCOs’ drugs blacklists part 2.

For type two diabetics, drugs will never be the answer ! The very best reduce HbA1c by two points. In my case, almost 12 to 10. Lowcarbing took me to HbA1c in the 5's. Three years on, HbA1c still in the fives. Only diabetes drug, Metformin at a cost of pennies per day to the NHS. Metformin can reduce HbA1c by 1.5. Diet and exercise far exceed what type two drugs can achieve, full stop ! And no side effects !

Drugs on PCOs’ blacklists-

• Amlodipine and olmesartan
• Atorvastatin
• Diclofenac spray gels
• Escitalopram
• Esomeprazole
• Exenatide
• Glucosamine
• Grazax
• Indacaterol
• Intanza
• Liraglutide
• Oilatum
• Oxycodone and naloxone
• Prednisolone enteric-coated tablets
• Rosuvastatin
• Sitagliptin
• Tadalafil
• Vildagliptin

Source: Pulse FOI of 134 PCOs

A comment on the Pulse site.

"I heard on Radio 5 live that GSK chief reportedly told his shareholders '90 percent of our drugs does not have the desired effect on 70% of patients. Looking at my experience on the prescriptions forced upon me by relatively inexperienced doctors in secondary care, I would say this statement is true. It makes sense to blacklist quite a few drugs in the market."

 
 
www.pulsetoday.co.uk/story.asp?storycode=4129104&cid=Latest_headlines_1_120411&sp_rid=NzIzMjE0NDA2NAS2&sp_mid=36490539

No comments: